Form 4: Melinda Litherland Pei Receives Stock Options and Restricted Stock Units in Rapid Micro Biosystems, Inc.

Director Melinda Litherland Pei received 14,300 shares of Class A Common Stock and options to purchase 28,650 shares of Class A Common Stock from Rapid Micro Biosystems, Inc. on May 23, 2024.

Summary

• On May 23, 2024, Melinda Litherland Pei, a director of Rapid Micro Biosystems, Inc. (RPID), received 14,300 shares of Class A Common Stock.
• These shares were granted as restricted stock units (RSUs) that vest on the earlier of the first anniversary of the grant date or the day before the next annual meeting, contingent upon continuous service.
• Pei also received options to purchase 28,650 shares of Class A Common Stock at an exercise price of $0.82.
• These options vest fully on the earlier of the first anniversary of the grant date or the day before the next annual meeting, also contingent upon continuous service.
• Following these transactions, Pei directly owns 14,300 shares of Class A Common Stock and options for 28,650 shares.

Sentiment

Score: 7

Explanation: The document reflects a standard executive compensation practice, which is generally viewed positively as it aligns management interests with shareholders. The sentiment is neutral to slightly positive.

Positives

• The grant of RSUs and stock options to a director aligns her interests with those of the shareholders.
• The vesting conditions tied to continuous service incentivize the director to remain with the company.

Future Outlook

The vesting of the RSUs and stock options is contingent upon the director's continuous service, suggesting an expectation of her continued involvement with the company.

Industry Context

Stock grants and options are common forms of executive compensation in the biotechnology industry, aligning management's interests with those of shareholders and incentivizing long-term value creation.

Comparison to Industry Standards

• Stock option grants are a standard component of compensation packages for directors and executives in publicly traded companies, particularly in growth-oriented sectors like biotechnology.
• The vesting schedules, typically tied to continued service, are also common practice to ensure retention and alignment of interests.
• Comparable companies in the life sciences sector, such as BioMérieux or Charles River Laboratories, also utilize stock options and restricted stock units as part of their executive compensation plans.

Stakeholder Impact

• Shareholders may view the stock and option grants positively as they incentivize the director to work towards increasing shareholder value.
• Employees may see this as a positive sign of the company's commitment to its leadership.

Key Dates